Moderna Inc (MRNA)

[Gpheart2016]

Investors need to stay calm and objective in the face of bad news. This is not a time to sell shares of MRNA. Revenue and earnings were way below estimates and we will see a short term drop in share price. But remember this company had earnings of -0.59 one year ago. Third quarter of 2021, $7.70 per share. Revenue increased from $157M to 4.97B! Is that a 3000% increase in revenue?
Let’s see if this bottoms out in the next day or so, then one should buy more shares or calls. The future of medicine is now m-RNA and Moderna is the leader.